Genzyme to pay $22M in whistle-blower lawsuit

Genzyme Corp. has agreed to pay a $22.3 million settlement in a lawsuit in which two former sales representatives alleged that the company said a product called Seprafilm could be used in a type of surgery for which it was not approved...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.